Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways October 2025

Will TCET wither on the vine before it can demonstrate success? We speak with former CMS official Laura Feindeiss. AdvaMed's Scott Whitaker on why medtech-specific sector arguments are resonating with the Trump administration. AMA's proposed CPT coding framework for AI software services that don’t involve a clinician work component; Key policy highlights from the The MedTech Conference; and Adi Renbaum on the importance of reimbursement planning for building a company's value proposition.

Read Article